Brief: Lineage Cell Therapeutics Reports First Quarter 2023 Financial Results

Lineage Cell Therapeutics

11/05/2023 21:42

May 11 (Reuters) - Lineage Cell Therapeutics Inc
 LCTX.A :
    * LINEAGE CELL THERAPEUTICS REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * TOTAL REVENUES FOR THREE MONTHS ENDED MARCH 31, 2023 WERE
APPROXIMATELY $2.4 MILLION,
    * LOSS FROM OPERATIONS FOR THREE MONTHS ENDED MARCH 31, 2023
WAS
$6.6 MILLION
    * LINEAGE CELL THERAPEUTICS: CASH, CASH EQUIVALENTS,
MARKETABLE
SECURITIES TOTALED $46.8 MILLION AS OF MARCH 31, SEES TO SUPPORT
PLANNED OPERATIONS INTO Q3 2024
    * QTRLY LOSS PER SHARE $0.03
    * Q1 EARNINGS PER SHARE VIEW $-0.04, REVENUE VIEW $2.0
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nBw5Cc0FMa 
Further company coverage:  LCTX.A 

 ((Reuters.Briefs@thomsonreuters.com;))